Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status
Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology.
- Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status
Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology.
- Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status
Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology.
- Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status
Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology.
- Next Pharmaceuticals Announces New Delivery Form for Relora®
Company announces that a microencapsulated concentrate version of the ingredient Relora® is now available.
- Next Pharmaceuticals Announces New Delivery Form for Relora®
Company announces that a microencapsulated concentrate version of the ingredient Relora® is now available.
- Next Pharmaceuticals Announces New Delivery Form for Relora®
Company announces that a microencapsulated concentrate version of the ingredient Relora® is now available.
- Next Pharmaceuticals Announces New Delivery Form for Relora®
Company announces that a microencapsulated concentrate version of the ingredient Relora® is now available.
- Next Pharmaceuticals Announces New Delivery Form for Relora®
Company announces that a microencapsulated concentrate version of the ingredient Relora® is now available.
- Next Pharmaceuticals Announces New Delivery Form for Relora®
Company announces that a microencapsulated concentrate version of the ingredient Relora® is now available.
- EuroPharma Appointed Exclusive US Distributor of New Omega-3 With Biological Absorption Level Higher than Other Fish Oils
EuroPharma has entered into an exclusive North American distribution agreement for Vectomega®, a natural marine complex made up of five different phospholipids, DHA and EPA, along with proteins and amino acids as they occur in nature.
- EuroPharma Appointed Exclusive US Distributor of New Omega-3 With Biological Absorption Level Higher than Other Fish Oils
EuroPharma has entered into an exclusive North American distribution agreement for Vectomega®, a natural marine complex made up of five different phospholipids, DHA and EPA, along with proteins and amino acids as they occur in nature.
- EuroPharma Appointed Exclusive US Distributor of New Omega-3 With Biological Absorption Level Higher than Other Fish Oils
EuroPharma has entered into an exclusive North American distribution agreement for Vectomega®, a natural marine complex made up of five different phospholipids, DHA and EPA, along with proteins and amino acids as they occur in nature.
- EuroPharma Appointed Exclusive US Distributor of New Omega-3 With Biological Absorption Level Higher than Other Fish Oils
EuroPharma has entered into an exclusive North American distribution agreement for Vectomega®, a natural marine complex made up of five different phospholipids, DHA and EPA, along with proteins and amino acids as they occur in nature.
- EuroPharma Appointed Exclusive US Distributor of New Omega-3 With Biological Absorption Level Higher than Other Fish Oils
EuroPharma has entered into an exclusive North American distribution agreement for Vectomega®, a natural marine complex made up of five different phospholipids, DHA and EPA, along with proteins and amino acids as they occur in nature.
- EuroPharma Appointed Exclusive US Distributor of New Omega-3 With Biological Absorption Level Higher than Other Fish Oils
EuroPharma has entered into an exclusive North American distribution agreement for Vectomega®, a natural marine complex made up of five different phospholipids, DHA and EPA, along with proteins and amino acids as they occur in nature.
- EuroPharma Appointed Exclusive US Distributor of New Omega-3 With Biological Absorption Level Higher than Other Fish Oils
EuroPharma has entered into an exclusive North American distribution agreement for Vectomega®, a natural marine complex made up of five different phospholipids, DHA and EPA, along with proteins and amino acids as they occur in nature.
- Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar
Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals
- Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar
Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals
- Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar
Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals
- Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar
Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals
- Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar
Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals
- Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar
Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals
- Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar
Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals
- Phase 2 White Bean Extract Receives GRAS Status
Company's branded white bean extract, Phase 2 Starch Neutralizer®, has been designated “generally recognized as safe,” (GRAS).
- Phase 2 White Bean Extract Receives GRAS Status
Company's branded white bean extract, Phase 2 Starch Neutralizer®, has been designated “generally recognized as safe,” (GRAS).
- Phase 2 White Bean Extract Receives GRAS Status
Company's branded white bean extract, Phase 2 Starch Neutralizer®, has been designated “generally recognized as safe,” (GRAS).
- Phase 2 White Bean Extract Receives GRAS Status
Company's branded white bean extract, Phase 2 Starch Neutralizer®, has been designated “generally recognized as safe,” (GRAS).
- Phase 2 White Bean Extract Receives GRAS Status
Company's branded white bean extract, Phase 2 Starch Neutralizer®, has been designated “generally recognized as safe,” (GRAS).
- Phase 2 White Bean Extract Receives GRAS Status
Company's branded white bean extract, Phase 2 Starch Neutralizer®, has been designated “generally recognized as safe,” (GRAS).
- Effective, Safe, Doctor-Recommended DiosVein(TM) from Europe Addresses Vein Conditions
Berg Imports offers DiosVein(TM), bioflavanoid-rich and derived from Sweet Orange, made from the supplement diosmin, targeted at promoting healthy circulation.
- Effective, Safe, Doctor-Recommended DiosVein(TM) from Europe Addresses Vein Conditions
Berg Imports offers DiosVein(TM), bioflavanoid-rich and derived from Sweet Orange, made from the supplement diosmin, targeted at promoting healthy circulation.
- Effective, Safe, Doctor-Recommended DiosVein(TM) from Europe Addresses Vein Conditions
Berg Imports offers DiosVein(TM), bioflavanoid-rich and derived from Sweet Orange, made from the supplement diosmin, targeted at promoting healthy circulation.
- Effective, Safe, Doctor-Recommended DiosVein(TM) from Europe Addresses Vein Conditions
Berg Imports offers DiosVein(TM), bioflavanoid-rich and derived from Sweet Orange, made from the supplement diosmin, targeted at promoting healthy circulation.
- Effective, Safe, Doctor-Recommended DiosVein(TM) from Europe Addresses Vein Conditions
Berg Imports offers DiosVein(TM), bioflavanoid-rich and derived from Sweet Orange, made from the supplement diosmin, targeted at promoting healthy circulation.
- China’s First Yogurt Drink Launched With EPA And DHA From Fish Oil
Company announces the launch of China’s first drinkable yogurt, OMU brand drinkable yogurt, enriched with MEG-3® brand Omega-3 EPA/DHA made from fish oil.
- China’s First Yogurt Drink Launched With EPA And DHA From Fish Oil
Company announces the launch of China’s first drinkable yogurt, OMU brand drinkable yogurt, enriched with MEG-3® brand Omega-3 EPA/DHA made from fish oil.
- China’s First Yogurt Drink Launched With EPA And DHA From Fish Oil
Company announces the launch of China’s first drinkable yogurt, OMU brand drinkable yogurt, enriched with MEG-3® brand Omega-3 EPA/DHA made from fish oil.
- China’s First Yogurt Drink Launched With EPA And DHA From Fish Oil
Company announces the launch of China’s first drinkable yogurt, OMU brand drinkable yogurt, enriched with MEG-3® brand Omega-3 EPA/DHA made from fish oil.
- China’s First Yogurt Drink Launched With EPA And DHA From Fish Oil
Company announces the launch of China’s first drinkable yogurt, OMU brand drinkable yogurt, enriched with MEG-3® brand Omega-3 EPA/DHA made from fish oil.
- P.L. Thomas and Polifenoles Naturales, S.A. Announce Strategic Alliance
Polifenoles Naturales, S.L. (POLINAT) European Research of Natural Products Center and producer of standardized fruit and botanical extracts and P. L. Thomas (PLT) have announced a strategic alliance to develop and market unique ingredients for the nutraceuticals, food and beverage markets.
- P.L. Thomas and Polifenoles Naturales, S.A. Announce Strategic Alliance
Polifenoles Naturales, S.L. (POLINAT) European Research of Natural Products Center and producer of standardized fruit and botanical extracts and P. L. Thomas (PLT) have announced a strategic alliance to develop and market unique ingredients for the nutraceuticals, food and beverage markets.
- P.L. Thomas and Polifenoles Naturales, S.A. Announce Strategic Alliance
Polifenoles Naturales, S.L. (POLINAT) European Research of Natural Products Center and producer of standardized fruit and botanical extracts and P. L. Thomas (PLT) have announced a strategic alliance to develop and market unique ingredients for the nutraceuticals, food and beverage markets.
- P.L. Thomas and Polifenoles Naturales, S.A. Announce Strategic Alliance
Polifenoles Naturales, S.L. (POLINAT) European Research of Natural Products Center and producer of standardized fruit and botanical extracts and P. L. Thomas (PLT) have announced a strategic alliance to develop and market unique ingredients for the nutraceuticals, food and beverage markets.
- P.L. Thomas and Polifenoles Naturales, S.A. Announce Strategic Alliance
Polifenoles Naturales, S.L. (POLINAT) European Research of Natural Products Center and producer of standardized fruit and botanical extracts and P. L. Thomas (PLT) have announced a strategic alliance to develop and market unique ingredients for the nutraceuticals, food and beverage markets.
- P.L. Thomas and Polifenoles Naturales, S.A. Announce Strategic Alliance
Polifenoles Naturales, S.L. (POLINAT) European Research of Natural Products Center and producer of standardized fruit and botanical extracts and P. L. Thomas (PLT) have announced a strategic alliance to develop and market unique ingredients for the nutraceuticals, food and beverage markets.
- Triarco’s Aminogen® Increases Plasma Amino Acid Levels Over 100%
Study comprising of 41 males was designed to find out whether the presence of Triarco’s patented ingredient Aminogen makes a difference in the breakdown, absorption and utilization of whey protein.
- Triarco’s Aminogen® Increases Plasma Amino Acid Levels Over 100%
Study comprising of 41 males was designed to find out whether the presence of Triarco’s patented ingredient Aminogen makes a difference in the breakdown, absorption and utilization of whey protein.
- Triarco’s Aminogen® Increases Plasma Amino Acid Levels Over 100%
Study comprising of 41 males was designed to find out whether the presence of Triarco’s patented ingredient Aminogen makes a difference in the breakdown, absorption and utilization of whey protein.
- Triarco’s Aminogen® Increases Plasma Amino Acid Levels Over 100%
Study comprising of 41 males was designed to find out whether the presence of Triarco’s patented ingredient Aminogen makes a difference in the breakdown, absorption and utilization of whey protein.
- First Endurance Launches Multi-V Containing Triarco’s Carbogen®
introducing Multi-V, formulation contains clinically effective doses of Triarco’s patented ingredient, Carbogen.
- First Endurance Launches Multi-V Containing Triarco’s Carbogen®
introducing Multi-V, formulation contains clinically effective doses of Triarco’s patented ingredient, Carbogen.
- First Endurance Launches Multi-V Containing Triarco’s Carbogen®
introducing Multi-V, formulation contains clinically effective doses of Triarco’s patented ingredient, Carbogen.
- First Endurance Launches Multi-V Containing Triarco’s Carbogen®
introducing Multi-V, formulation contains clinically effective doses of Triarco’s patented ingredient, Carbogen.
- First Endurance Launches Multi-V Containing Triarco’s Carbogen®
introducing Multi-V, formulation contains clinically effective doses of Triarco’s patented ingredient, Carbogen.
- Serotain® Scores Almost 70% on SSRI Bioassay
- Serotain® Scores Almost 70% on SSRI Bioassay
- Serotain® Scores Almost 70% on SSRI Bioassay
- Serotain® Scores Almost 70% on SSRI Bioassay
- Triarco Introduces Rhodavin(TM)
- Triarco Introduces Rhodavin(TM)
- Triarco Introduces Rhodavin(TM)
- Triarco Introduces Rhodavin(TM)
- Alphastat® Clinical Trial Results
- Alphastat® Clinical Trial Results
- Alphastat® Clinical Trial Results
- Alphastat® Clinical Trial Results
- Enzymotec Announces Introduction of a New Ingredient – AlphaGPC
Company introduces product to complement cognitive health-targeted line.
- Enzymotec Announces Introduction of a New Ingredient – AlphaGPC
Company introduces product to complement cognitive health-targeted line.
- Enzymotec Announces Introduction of a New Ingredient – AlphaGPC
Company introduces product to complement cognitive health-targeted line.
- Tate & Lyle Interim Results Announcement 2009
Tate & Lyle has announced their 2009 Interim results, reporting the Group's performance, before the impact of exchange translation, remains on track to meet our expectations for the full year.
- NPI Daily - Top of The News for Nov. 6, 2009 - National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters
Nature's Sunshine Products Reports FY09 Q3 Operating Results; SunOpta Announces FY09 Q3 Results; Tate & Lyle Interim Results Announcement 2009; NOW Foods Receives the 2009 Illinois Governor's Sustainability Award; Transport-C Supports Vitamin Angels at SSW; Cantox at Supplyside West; New Support Showing Immunoglobulin Supplementation Enhances Immune System; FDA Warning: Over-the-Counter Sex Enhancement Drug May Cause 'Dangerously' Low Blood Pressure; EPAX AS Achieves 'Friend of the Sea' Certification; National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters; Fast-C™ At SupplySide West: US Clinical Trials Data Available In Booth ; Nutty Flavor & Healthy Boost of Omega-3 Make Hemp Seed an Ideal Ingredient; DSM's tensVida® Recognized for Innovative Development; Nutrition 21 Announces Addition of Innovative New Probiotic + Omega-3 Fish Oil Combination Product; Glanbia Nutritionals Offers More Than Ingredients for Nutritional Beverages; Whole Foods Market(R) Offers Natural Solutions to Help Build Up Body Defenses With Immune System Support; Doug Reyes Joins Embria as Regional Sales Manager; Michael F. Hines Joins Board of General Nutrition Centers, Inc.; Dr. Arnold Hirsch Celebrates 50th Anniversary with the American Chemical Society
- NPI Daily - Top of The News for Nov. 6, 2009 - National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters
Nature's Sunshine Products Reports FY09 Q3 Operating Results; SunOpta Announces FY09 Q3 Results; Tate & Lyle Interim Results Announcement 2009; NOW Foods Receives the 2009 Illinois Governor's Sustainability Award; Transport-C Supports Vitamin Angels at SSW; Cantox at Supplyside West; New Support Showing Immunoglobulin Supplementation Enhances Immune System; FDA Warning: Over-the-Counter Sex Enhancement Drug May Cause 'Dangerously' Low Blood Pressure; EPAX AS Achieves 'Friend of the Sea' Certification; National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters; Fast-C™ At SupplySide West: US Clinical Trials Data Available In Booth ; Nutty Flavor & Healthy Boost of Omega-3 Make Hemp Seed an Ideal Ingredient; DSM's tensVida® Recognized for Innovative Development; Nutrition 21 Announces Addition of Innovative New Probiotic + Omega-3 Fish Oil Combination Product; Glanbia Nutritionals Offers More Than Ingredients for Nutritional Beverages; Whole Foods Market(R) Offers Natural Solutions to Help Build Up Body Defenses With Immune System Support; Doug Reyes Joins Embria as Regional Sales Manager; Michael F. Hines Joins Board of General Nutrition Centers, Inc.; Dr. Arnold Hirsch Celebrates 50th Anniversary with the American Chemical Society
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Taming Fear of the H1N1 Flu Vaccine
- Taming Fear of the H1N1 Flu Vaccine
- Natural Cold and Flu Remedies: Do They Help?
- Natural Cold and Flu Remedies: Do They Help?
- Exercise as Pain Therapy
- Exercise as Pain Therapy
|
EDEN PRAIRIE, MN (February 7, 2006) – MHP (Maximum Human Performance) recently introduced Anadrox™, a potent combination muscle growth/fat burning product which contains 7-Keto®, a branded ingredient from Humanetics Corporation of Minnesota.
Anadrox contains the potent, fat-burning matrix, Thermo-Z7™, an exclusive patent-protected compound that contains 7-Keto. “We were looking for a premium, fat-burning ingredient that was well-researched and supported by solid science and that search lead us to 7-Keto,” says Steve Marada, Chief Operating Officer, Maximum Human Performance. 7-Keto (3-acetyl-7-oxo dehydroepiandrosterone) is a non-stimulant, thermogenic agent that is clinically proven to increase metabolism and promote healthy weight loss. 7-Keto has been proven to enhance the activity of three thermogenic enzymes – Glycerol-3-phosphate dehydrogenase, Malic Enzyme & Fatty Acyl CoA Oxidase – and subsequently, promote the utilization of fat stores – namely, to burn fat. In addition, two independently conducted clinical trials support the effectiveness of 7-Keto for weight loss. Both trials were double-blinded and placebo-controlled, and have been published in peer-reviewed journals. 7-Keto was shown to promote 3 times more weight and fat loss then diet and exercise alone.
“MHP is a strong partner for us and it’s exciting to work with a progressive company that can take 7-Keto in new directions,” says Scott Steil, VP of Sales & Marketing, Humanetics Corporation. “Partnering with companies like MHP, that use solid science to drive their product development process, ultimately provides consumers with a safe, efficacious product that will help them achieve their goals. In addition to giving 7-Keto solid footing in the sports nutrition industry, this gives Humanetics an excellent opportunity to showcase the fat-burning properties of 7-Keto in a breakthrough formula like Anadrox.
About MHP The MHP partnership was formed between World Class Bodybuilder, Gerard Dente, and Dr. Vincent Giampapa, MD, a world-renowned hormonal manipulation and anti-aging physician and in 1997, Maximum Human Performance was born. Combining the expertise of scientists, doctors, sports nutritionists and biochemists, MHP has made it possible to provide consumers with the most technologically advanced sports nutrition supplements available through modern science. For more information, visit www.maxperformance.com.
About Humanetics Corporation Founded in 1988, Humanetics Corporation is a privately held corporation focused on providing proprietary, science-based solutions to consumer health and aging concerns. In addition to 7-Keto®, Humanetics Corporation markets MicroLactin® for inflammation and joint health and Inzitol™ for glucose transport and creatine uptake by muscle cells. For more information, visit www.humaneticsingredients.com.
### |